Immunoglobulin E antileishmanial antibody response in cutaneous leishmaniasis

Clinical and Diagnostic Laboratory Immunology

Volumn 9, Issue 1, 2002, Pages 101-104

  Sousa Atta, Maria L B ^a   Salamé, Gregório S ^a   D'Oliveira Jr , Argemiro ^a   Almeida, Roque P ^a   Atta, Ajax M ^a   Carvalho, Edgar M ^a  

^a Hospital Universitario   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN E; PARASITE ANTIBODY;

ADOLESCENT; ADULT; ANTIBODY DETECTION; ANTIBODY RESPONSE; ARTICLE; BRAZIL; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNE RESPONSE; IMMUNOPATHOLOGY; IMMUNOREGULATION; LEISHMANIA; MALE; NONHUMAN; PRIORITY JOURNAL; SCHOOL CHILD; SERODIAGNOSIS; SKIN LEISHMANIASIS; SKIN TEST; SKIN ULCER;

ADOLESCENT; ADULT; ANIMALS; ANTIBODIES, PROTOZOAN; CHILD; FEMALE; HUMANS; IMMUNOGLOBULIN E; LEISHMANIA BRAZILIENSIS; LEISHMANIASIS, CUTANEOUS; MALE; MIDDLE AGED;

EID: 0036148346     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/CDLI.9.1.101-104.2002     Document Type: Article

References (29)

1. Differential decline in Leishmania membrane antigen-specific immunoglobulin G (IgG), IgM, IgE, and IgG subclasses antibodies in Indian Kal-Azar patients after chemotherapy
2. Anti-leishmanial IgE antibodies: A marker of active disease in visceral leishmaniasis
3. Determination of the cytokine profile in American cutaneous leishmaniasis using the polymerase chain reaction
4. Cell-mediated immunity in American visceral leishmaniasis: Reversible immunosuppression during acute infection
5. Absence of gamma-IFN and interleukin-2 production during active visceral leishmaniasis
6. Cell-mediated immunity in American cutaneous and mucosal leishmaniasis
7. Immunological markers of clinical evolution in children recently infected with Leishmania donovani chagasi
8. Clinical and immunopathological aspects of disseminated cutaneous leishmaniasis
9. Characterization of the cellular immune response in American cutaneous leishmaniasis
10. A statistically defined endpoint titer determination method for immunoassays
11. Characterization of the local and systemic immune responses in patients with cutaneous leishmaniasis due to Leishmania major
12. Polyclonal B cell activation, circulating immune complexes and autoimmunity in human American visceral leishmaniasis
13. Production of interferon-gamma, interleukin-2, interleukin-4 and interleukin-10 by CD4+ lymphocytes in vivo during healing and progressive murine leishmaniasis
14. Potential role for interleukin-10 in the immunosuppression associated with kala-azar
15. Cytokines and T cells in host defense
16. Leishmania parasites and their ploys to disrupt macrophage activation
17. Cleavage of the head of Bacteriophage
18. IL-13 is a susceptibility factor for Leishmania major infection
19. Increased expression of proinflammatory cytokines in chronic lesions of human cutaneous leishmaniasis
20. Leishmaniasis
21. Leishmania (viannia) panamensis-specific IgE and IgA antibodies in relation to expression of human tegumentary leishmaniasis
22. IgE elevation and IgE anti-malarial antibodies in Plasmodium falciparum malaria: Association of high IgE levels with cerebral malaria
23. Cytokine patterns in the pathogenesis of human leishmaniasis
24. Down-regulation of Th1 type of response in early human American cutaneous leishmaniasis
25. A mite subversive: Cleavage of CD23 and CD25 by Der p 1 enhances allergenicity
26. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications
27. Altered immune responses and susceptibility to Leishmania major and Staphylococcus aureus infection in IL-18 deficient mice
28. Role of specific immunoglobulin E in diagnosis of acute Toxoplasma infection and toxoplasmosis
29. Determinants of the immune response in visceral leishmaniasis: Evidence for predominance of endogenous IL-4 over IFN-gamma production